← Browse by Condition
Medical Condition
esrd end stage renal disease
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 3
NCT06878560 Phase 1, Phase 2
Recruiting
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Enrollment
50 pts
Location
United States
Sponsor
United Therapeutics
NCT06933472 Phase 3
Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Enrollment
264 pts
Location
United States, China
Sponsor
Alebund Pharmaceuticals